The Association of Clinical Research Organizations (ACRO) has elected David Simmons, chairman and chief executive officer of PPD, as its 2016 chairman, and John Hubbard, president and chief executive officer of Bioclinica, as vice chairman.
 
“ACRO plays a vital role in promoting the interests of the CRO industry globally,” said Mr. Simmons. “Not only does ACRO represent the industry on legislative and regulatory matters but, increasingly, the association helps build relationships with the sponsor, research site, investigator and patient communities. I look forward to leading the organization in 2016 as we pursue a focused and productive agenda.”   
 
In addition to its legislative and regulatory efforts, ACRO is exploring new ways to improve areas such as patient recruitment, workforce development and clinical trial efficiency.
 
“ACRO successfully advanced CRO industry interests in 2015 by influencing health and tax policy in the United States and navigating the implementation of the Clinical Trial Regulation in the European Union,” said ACRO executive director Doug Peddicord, Ph.D. “We will build on our successes this year and continue to promote our industry through our robust communications and advocacy programs.”
 
ACRO also elected as officers: Judd Hartman, general counsel of PPD, as treasurer; and Maria Kraus, executive vice president of corporate development and strategy at Bioclinica, as secretary.